NASDAQ:NTLA - Intellia Therapeutics, Inc.
$17.64
 $0.54
+3.16%
4:00PM EDT
2019-07-22
Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide RNA sequence. The Cas9 protein acts like a pair of molecular scissors that initiates the natural cellular repair process to knockout, repair or insert a gene. The guide RNA sequence recognizes and directs the Cas9 to a specific target deoxyribonucleic acid (DNA) sequence. The Company's sentinel in vivo programs focus on the use of Lipid Nanoparticle (LNPs) for delivery of the CRISPR/Cas9 complex to the liver. The Company's division, eXtellia Therapeutics, is focused on the application of CRISPR/Cas9 genome editing in the fields of immuno-oncology and autoimmune and inflammatory diseases. The Company's subsidiary is Intellia Securities Corp. As of September 30, 2016, the Company had not generated any revenue. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  NTLA     avg for
industry  
  avg for
sector  
42 stocks weight:  59. 70   217. 37   399. 45  
42 stocks rank:  2. 24 K 1. 27 K 716. 99  
# analyst opinions:  10. 00   13. 21   13. 71  
mean recommendation:  1. 90   2. 10   2. 04  

quick ratio:  7. 65   5. 49   1. 88  
current ratio:  7. 74   5. 87   2. 36  

target price low:  16. 00   83. 44   114. 90  
target price avg:  28. 55   106. 20   137. 90  
target price high:  18. 30   132. 30   158. 97  
1-yr high:  31. 99   111. 86   142. 57  
last close:  17. 10   86. 79   125. 44  
50-day avg:  15. 33   86. 68   122. 63  
200-day avg:  16. 37   89. 22   121. 38  
1-yr low:  11. 39   69. 78   100. 51  
volume:  397. 77 K 2. 62 M 3. 43 M
50-day avg volume:  579. 02 K 3. 20 M 4. 16 M
200-day avg volume:  623. 94 K 2. 99 M 4. 75 M

1-day return:  -0. 64 % -1. 30 % -0. 99 %
this week return:  3. 01 % 0. 45 % -0. 20 %
12-wk return:  0. 35 % 0. 94 % 4. 84 %
52-wk return:  -43. 48 % -1. 30 % 10. 55 %

enterprise value (EV):  504. 59 M 45. 10 B 122. 38 B
market cap:  781. 66 M 38. 96 B 108. 40 B
EBITDA:  -87. 50 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -5. 77   5. 38   11. 93  
enterprise/revenue (EV/R):  15. 11   57. 92   10. 21  
total revenue:  33. 40 M 9. 91 B 39. 98 B
total debt:  19. 51 M 10. 90 B 17. 48 B
debt/equity:  7. 38   57. 18   120. 05  
net income (common):  -85. 93 M 2. 07 B 4. 05 B

shares outstanding:  45. 22 M 538. 09 M 1. 24 B
shares:  35. 92 M 548. 00 M 1. 22 B
shares short:  8. 21 M 10. 98 M 11. 87 M
shares short prior month:  8. 11 M 9. 32 M 12. 05 M
short ratio:  11. 68   5. 60   3. 34  
short % of float:  21. 68 % 6. 48 % 2. 64 %
total cash/share:  6. 49   10. 98   9. 19  
total cash:  296. 58 M 5. 93 B 6. 10 B
free cash flow:  -29. 31 M 2. 92 B 4. 55 B
operating cash flow:  -64. 94 M 3. 80 B 5. 78 B

book value:  5. 81   13. 35   27. 45  
price/book:  2. 94   4. 60   8. 78  
gross profits:  -58. 68 M 7. 44 B 36. 13 B
operating margins:  -276. 21 % -308. 40 % -28. 55 %
EBITDA margins:  -261. 99 % 13. 17 % 23. 38 %
profit margins:  -257. 28 % 10. 44 % 14. 18 %
gross margins:  -170. 47 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -1. 96   2. 10   4. 23  
forward EPS:  -2. 82   3. 45   7. 10  
P/E:  -8. 73   1. 90   32. 10  
forward P/E:  -6. 06   6. 46   15. 47  
PE/G:  -0. 22   0. 70   -0. 54  
growth:  39. 70 % 265. 63 % 79. 11 %
earnings high:  -0. 47   0. 89   1. 68  
earnings avg:  -0. 60   0. 70   1. 57  
earnings low:  -0. 79   0. 46   1. 46  
revenue high:  10. 63 M 2. 57 B 11. 07 B
revenue avg:  7. 11 M 2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -16. 38 % -2. 34 % 5. 28 %
return on equity:  -30. 70 % -90. 08 % 133. 53 %
revenue growth:  39. 70 % 265. 25 % 73. 68 %
revenue/share:  0. 76   12. 72   60. 04  

beta (1yr vs S&P500):  2. 35   1. 27   0. 91  
sharpe (1yr):  -0. 57   0. 16   0. 77  

held % insiders:  22. 51 % 6. 06 % 3. 29 %
held % institutions:  71. 58 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : NTLA
.    123.921 =       123.921 :: --> INITIAL WEIGHT <--
.    - 1.959 =       121.962 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.228 =       271.681 :: P/E factor
.     x 1.46 =       396.749 :: PE/G factor
.    x 1.449 =       574.925 :: beta factor
.    x 0.842 =       484.141 :: sharpe factor
.    x 2.681 =      1297.888 :: current ratio factor
.    x 1.073 =      1392.044 :: quick ratio factor
.    x 1.042 =      1450.411 :: short ratio factor
.    x 1.568 =      2273.847 :: revenue growth factor
.    x 1.261 =       2866.92 :: EV/R factor
.     x 1.03 =      2951.769 :: price-to-book factor
.    x 1.712 =       5052.18 :: debt-to-revenue factor
.    x 1.063 =      5368.393 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     11385.251 :: sector+industry 1-year gains factor
.    x 1.009 =     11492.592 :: industry 12-weeks return factor
.    x 1.308 =      15031.03 :: industry 2-weeks return factor
.    x 0.897 =     13480.903 :: company one-year gains+dividend factor
.    x 3.569 =     48116.514 :: company 13 weeks' performance factor
.    x 1.059 =     50974.991 :: 5-day avg > 200-day avg
.    x 1.418 =       72299.3 :: 5-day avg > 50-day avg
.    x 0.998 =     72123.613 :: "drift" penalty 4 days ago
.    / 2.034 =     35467.599 :: overall "drift" factor
.    x 0.861 =     30541.486 :: largest single-day jump factor
.        x 1 =     30541.486 :: volatility factor
.        x 1 =     30541.486 :: 42-day volatility factor
.     x 1.32 =      40327.99 :: notable returns + performance factor
.    x 3.208 =    129376.543 :: performance vs s&p500 factor
.    x 3.329 =    430743.121 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.719 =    309670.338 :: forward EPS factor
.    x 0.898 =    278041.075 :: forward P/E factor
.    x 1.185 =    329398.736 :: industry recommendation factor
.    x 2.408 =    793182.977 :: company recommendation factor
.    x 1.003 =    795376.432 :: factor historical industry gain for week 29
.    x 9.928 =   7896120.612 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        53.009 :: reduced for readability
.    + 6.693 =        59.703 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     59.703 :: FINAL WEIGHT for NASDAQ:NTLA


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org